Growth Trends in the Stem Cell Manufacturing Market, 2024-2028: Rising Federal Investments in Stem Cell Therapy Driving the Industry
10 janv. 2025 09h24 HE
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Stem Cell Manufacturing Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The stem cell manufacturing market is forecasted...
Regenerative Medicine Market Size to Hit USD 235.98 Billion by 2032, Driven by Advancements in Cell Therapy and Stem Cells – SNS Insider
08 janv. 2025 08h00 HE
|
SNS Insider pvt ltd
Pune, Jan. 08, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Regenerative Medicine Market was estimated at USD 32.50 billion in 2023 and is projected to reach USD 235.98 billion in 2032,...
Stem Health Plus Revolutionizes Skin Regeneration with Advanced Stem Cell Skin Graft Technology
31 déc. 2024 11h56 HE
|
Stem Health Plus
Stem Health Plus is an innovative leader in the medical supplies industry, providing stem cell skin grafts to improve recovery times.
Bone Marrow Aspirate Concentrates Industry Report, Featuring Profiles of 45+ Key Players Including Arthrex, Cesca Therapeutics, Globus Medical, Ranfac, Terumo and Zimmer Biomet Holdings
11 déc. 2024 11h39 HE
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Bone Marrow Aspirate Concentrates - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Bone...
Stem Cell Therapy Market Is Expected To Reach Revenue Of USD 54.7 Bn By 2033, At 12.6% CAGR: Dimension Market Research
11 déc. 2024 09h08 HE
|
Dimension Market Research
New York, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Overview The Global Stem Cell Therapy Market is projected to reach USD 18.9 billion in 2024 which is further anticipated to reach USD 54.7 billion by...
Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024
02 déc. 2024 09h05 HE
|
Longeveron
Longeveron will participate in the Emerging Growth Virtual Conference with company presentation December 5th at 12:00pm ET.
Stem Cell Therapy Strategic Business Report 2024 - Allogeneic Stem Cell Therapy Segment is Expected to Reach US$1 Billion by 2030 with a CAGR of a 16.7%
02 déc. 2024 04h23 HE
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Stem Cell Therapy was...
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update
12 nov. 2024 16h05 HE
|
Longeveron
Longeveron reports 3Q24 financial results. Pivotal Phase 2b clinical trial in HLHS achieves 80% enrollment. Positive Phase 2 data for Alzheimer's disease.
Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)
11 nov. 2024 09h05 HE
|
Longeveron
Longeveron has appointed Devin Blass as Chief Technology Officer (CTO) and SVP of CMC, effective Dec 2, adding capabilities ahead of potential BLA filing.
Stem Cell Therapy Market Analysis Report 2024-2029: iPSC Technology and Personalized Medicine Trends Drive Growth
06 nov. 2024 05h12 HE
|
Research and Markets
Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy Market: Analysis By Type, By Stem Cell Source, By Application, By End User, By Region Size and Trends Forecast up to 2029" report has...